Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. - Wikidata - awgldk - TriplyDB

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

http://www.wikidata.org/entity/Q27472961

about

The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A Diverse functions of RNase L and implications in pathology Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response Evidence for a functional RNA element in the hepatitis C virus core gene The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response Regulation of hepatic innate immunity by hepatitis C virus Innate immune responses in hepatitis C virus infection Coronavirus gene 7 counteracts host defenses and modulates virus virulence Cell-free replication of the hepatitis C virus subgenomic replicon.Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA RNase L plays a role in the antiviral response to West Nile virus.Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells Evasion of intracellular host defence by hepatitis C virus Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C An interferon response gene signature is associated with the therapeutic response of hepatitis C patients Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C.Intracellular innate immune cascades and interferon defenses that control hepatitis C virus RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R.Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L Regulation of coronaviral poly(A) tail length during infection.The quest for an efficacious antiviral for respiratory syncytial virus.Is flavivirus resistance interferon type I-independent?Functionally conserved architecture of hepatitis C virus RNA genomes.OASes and STING: adaptive evolution in concert Hepatitis C Virus. Strategies to Evade Antiviral Responses Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.Pathologic effects of RNase-L dysregulation in immunity and proliferative control.Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection Interplay between viruses and host mRNA degradation Interaction of hepatitis C virus with the type I interferon system.Treatment failure in hepatitis C: mechanisms of non-response.Antagonism of RNase L Is Required for Murine Coronavirus Replication in Kupffer Cells and Liver Sinusoidal Endothelial Cells but Not in Hepatocytes.Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.

P2860

Q24632380-2C40F555-6EBF-4D4A-B97F-6E3EAD3D439E Q24652347-73BEF060-DDC2-4C9E-9E76-C63D2C8EA4EB Q24681387-41096B58-4FB4-4DEB-9AD6-EB7A13CDFBC2 Q24682695-5075238A-57D7-480C-876D-ACE85242CED8 Q26772138-7C2B566C-2A7F-4290-B569-92A4953FD314 Q26824743-234AFB0F-316B-432F-B93C-59B2273B179A Q27023055-07F5A0B7-90F5-4A16-8845-BF6F534161BF Q27349527-F60B94B2-251D-4BF1-A9B7-7F2D17F1841C Q27472942-3E0A623D-1548-4BB8-BE58-80267023FD5C Q27472970-CB939C48-2B85-4B13-942C-7589866537D0 Q27473045-0EC4EB35-5FE0-4205-A1D6-0F74DCBD8B32 Q27478062-0E30913A-EEDF-4B88-8550-5340AADB6097 Q27485064-CC2F65C8-7B8B-43A3-874C-73508E819638 Q27489040-E51F975D-F6FA-4A39-8178-B704ABBB1314 Q28513485-91EDAF53-D7B8-439F-8ABA-BBCAD16A8AA0 Q29618976-17863060-5B5F-4A33-AF51-68CDD4D0DBB3 Q33714369-C8BA4348-E8F8-4EA8-8141-4450FF72C148 Q33898567-2210EE92-910A-49E8-8069-6B6FB693E24C Q34027569-9089E12F-7D64-41DD-954C-D6F6A3CEE239 Q34174547-42FD4B2A-C492-4400-9D61-2BA3BD15DB05 Q34208090-9BF6D793-48F7-45EE-9D58-6E25D27D06C0 Q34210374-FCABB178-DDBC-4F5C-A346-85FC76FF0B51 Q34211621-83EE87B5-5EA0-4E1C-B6EE-90F0FC287A51 Q34466906-E2A1CF24-7714-4245-8E11-2D98A25C6F2B Q34795484-468F8A04-FE53-4A79-B386-0AE327B60F02 Q34907070-A6363F18-4B8F-48A1-B0E5-8710CB8E391A Q35115949-F41F0EC4-C08C-4B1D-A0AF-DC1ADDFFB7BD Q35129750-F0FCE28F-64C4-4B18-AFB9-50BE93862EB1 Q35229364-1B931A9C-C8C2-4002-BBF8-375C295507E8 Q35569805-BBE08077-354D-4B22-A0C2-45B2F02B1AB9 Q35604054-D6B51011-235D-4CED-92D0-F359F98DAE62 Q35689692-A4C84AFB-9BC0-4B11-B766-50B96936DFCA Q35857644-3DEFD755-065E-4C88-9423-3483050C53C3 Q36310770-410E17D6-B9A2-4424-B6EA-271F519BE0DB Q36460968-7662A7B0-AA85-41B3-8411-044A64C52CF0 Q36785197-4BB18E6A-852B-4364-9151-5718E1A0C157 Q36935522-FE679212-7F26-47D6-9314-EA8913E824A6 Q37345286-1C4BAD04-4E83-4B39-BE55-05F14D30CE29 Q37347335-96A99D76-355C-44A9-975B-D00729002306 Q37711751-4DBFE8E6-5184-4B17-B5DB-21E6260B23C4

P2860

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

http://www.wikidata.org/entity/Q27472961

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Activation and evasion of the ...... hway by hepatitis C virus mRNA

@nl

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@ast

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@en

type

label

Activation and evasion of the ...... hway by hepatitis C virus mRNA

@nl

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@ast

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@en

prefLabel

Activation and evasion of the ...... hway by hepatitis C virus mRNA

@nl

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@ast

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@en

P1433

Q27472961-5EA40D10-ADF1-4E25-A7B6-1B6744BA4C50

P1476

Q27472961-69806328-F66B-4037-BFCD-EE7EB44178E5

P2093

Q27472961-BB2049AF-420A-4330-B086-E469AC55CCF2

Q27472961-EE28D821-AB70-44E5-A89E-B3FB1ECAEBB9

P2860

Q27472961-026FC1A5-2E95-4EDE-95B4-FD3894785012

Q27472961-02E36ACD-686C-44AD-B2FB-D1DC78FEBF26

Q27472961-079E4C81-5225-48EF-9780-A61F9DEF96A6

Q27472961-07F2DC1C-E9D7-4683-A36B-09A49720EAA3

Q27472961-0EA4DCBE-6FE6-4486-9AD5-29214E6D3FE2

Q27472961-1F25BABD-478E-46E4-8C09-1155F3FC86C5

Q27472961-2099652D-3B2B-4EA8-97CA-8A3C5A4B159C

Q27472961-27E0B9A3-3176-4062-8A66-DB9D00D5DA18

Q27472961-28542BE1-3560-4FAA-A105-A35030CDC109

Q27472961-34C4CF58-351F-4719-BC1D-0F48CEA3BA63

P304

Q27472961-BFE2D1E3-4A30-4601-8842-FCAD34C1F347

P31

Q27472961-16B8AB05-CAA2-4709-B160-6FBA92CC3104

P356

Q27472961-38AC02F3-E581-4209-86E7-80686656A01D

P407

Q27472961-46499D96-716B-4E0F-9025-7A36F4116CBA

P433

Q27472961-0DF191B2-E42F-4FD3-A2EC-B636A653DE90

P478

Q27472961-19945C62-70E5-44FB-AB96-F2764162B137

P577

Q27472961-443DEA36-FD27-4EF9-B96E-6E9C2CB4F1B1

P5875

Q27472961-A8A36FC4-0ABA-4CDE-BFC9-8DE60094E279

P698

Q27472961-59C32000-9882-44FD-8E1B-310822FB73DA

P921

Q27472961-0FD7EFD7-CC06-44EF-8445-FC89F1AAB121

P932

Q27472961-A61B75CC-6C56-4496-88A4-547A6BA14CAF

P356

S1355838202020617

P1433

P1476

Activation and evasion of the ...... way by hepatitis C virus mRNA.

@en

P2093

David J Barton

http://www.w3.org/2001/XMLSchema#string

Jian-Qiu Han

http://www.w3.org/2001/XMLSchema#string

P2860

Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Codon usage tabulated from international DNA sequence databases: status for the year 2000

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.

Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA

Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA

P304

512-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1355838202020617

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11378084

http://www.w3.org/2001/XMLSchema#string

P698

11991644

http://www.w3.org/2001/XMLSchema#string

P921

P932

1370272

http://www.w3.org/2001/XMLSchema#string